Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

TOward the Lowest Effective DOse of Abatacept or Tocilizumab (TOLEDO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01557374
Recruitment Status : Active, not recruiting
First Posted : March 19, 2012
Last Update Posted : February 5, 2019
Sponsor:
Collaborator:
Ministry of Health, France
Information provided by (Responsible Party):
Assistance Publique - Hôpitaux de Paris

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : June 2021
Estimated Study Completion Date : June 2021